Meeting - Pamplona, Spain
The II Frontiers in Oncology meeting "The presence and future of the RAS pathway: from function and genomics to inhibition" will feature the latest advances in the study of the RAS pathway aiming to cover aspects from basic research to translational and clinical investigation.
Among the topics that will be presented are novel mouse models that recapitulate human carcinogenesis and serve as preclinical platforms for drug testing, cutting-edge approaches for the identification of novel vulnerabilities and regulators of the RAS pathway, as well as current inhibitory strategies for the treatment of RAS-driven cancers.
*The meeting will bring together European and US leaders in the RAS field and will constitute an ideal framework to promote and improve both international cooperation and scientific exchange among RAS community members.
Among the topics that will be presented are novel mouse models that recapitulate human carcinogenesis and serve as preclinical platforms for drug testing, cutting-edge approaches for the identification of novel vulnerabilities and regulators of the RAS pathway, as well as current inhibitory strategies for the treatment of RAS-driven cancers.
*The meeting will bring together European and US leaders in the RAS field and will constitute an ideal framework to promote and improve both international cooperation and scientific exchange among RAS community members.
- Organization: Center for Applied Medical Research (CIMA)
Mon, Oct 05, 2015 - Wed, Oct 07, 2015
Museum of the University of Navarra
Pamplona, Spain
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
